Beyond Parkinsonism: 18 F-FDOPA Brain PET/MRI for Detection of High-grade Glioma

Michelle Chen1, Martin Niethammer2, Ana M Franceschi1

  • 1Department of Radiology, Neuroradiology Division, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.

Clinical Nuclear Medicine
|January 19, 2026
PubMed

Insights

A patient with parkinsonism symptoms was diagnosed with glioblastoma using 18F-FDOPA PET/MRI. This imaging technique revealed an unexpected tumor in the brain

Area of Science:

  • Neuroimaging
  • Neurology
  • Oncology

Background:

  • A 72-year-old male presented with parkinsonian symptoms, but clinical presentation was atypical for degenerative parkinsonism.
  • Initial MRI revealed splenium T2/FLAIR hyperintensity, initially presumed to be small vessel disease.

Purpose of the Study:

  • To investigate the cause of atypical parkinsonism and splenium abnormalities.
  • To evaluate the utility of 18F-FDOPA PET/MRI in differentiating parkinsonism and assessing brain lesions.

Main Methods:

  • Performed 18F-FDOPA brain PET/MRI to assess for degenerative parkinsonism.
  • Utilized contrast-enhanced MRI to further characterize the splenium lesion.
  • Conducted stereotactic biopsy for histopathological confirmation.

Main Results:

  • 18F-FDOPA PET/MRI excluded degenerative parkinsonism and showed high tracer uptake in the splenium (SUVmax 4.46).
  • Contrast-enhanced MRI identified a peripherally enhancing splenium lesion suggestive of neoplasm.
  • Biopsy confirmed diffuse high-grade glioblastoma, IDH-wildtype, WHO Grade 4.

Conclusions:

  • 18F-FDOPA PET/MRI can be crucial in diagnosing primary brain tumors presenting with atypical neurological symptoms.
  • This case highlights the value of 18F-FDOPA PET in identifying and characterizing brain neoplasms.

Related Concept Videos

MRI and PET in Mouse Models of Myocardial Infarction10:46

MRI and PET in Mouse Models of Myocardial Infarction

We describe how to perform MRI and PET imaging of the mouse heart. The protocol is tailored to assess treatment efficacy in models of myocardial infarction and heart...
12.3K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

In the past, small animal irradiation was usually performed without the ability to target a well-delineated tumor volume. The goal was to mimic the treatment of human glioblastoma in rats. Using a small animal irradiation platform, we performed MRI-guided 3D conformal irradiation with PET-based sub-volume boosting in a preclinical...
10.0K
Co-culturing Glutamatergic Neurons and Pediatric High-Grade Glioma Cells04:27

Co-culturing Glutamatergic Neurons and Pediatric High-Grade Glioma Cells

This video showcases a technique for co-culturing glutamatergic neurons and pediatric high-grade glioma (pHGG) cells within a microfluidic device. Human induced pluripotent stem cells are introduced into the microfluidic system and incubated to promote their differentiation into mature cortical glutamatergic neurons. Following this, the pHGG cells are introduced onto the mature neurons, establishing a co-culture and enabling interactions between neurons and pHGG...
392
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

IDH1-mutant diffuse low-grade gliomas are rare tumors that are difficult to culture. We introduce a simple, non-enzymatic explant method that preserves IDH1-mutant protein expression and sustains cultures for months. Importantly, this technique works with cryopreserved tumors, offering a valuable resource for glioma...
1.1K
Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia10:35

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia

The method presented here uses simultaneous positron emission tomography and magnetic resonance imaging. In the cerebral hypoxia-ischemia model, dynamic changes in diffusion and glucose metabolism occur during and after injury. The evolving and irreproducible damage in this model necessitates simultaneous acquisition if meaningful multi-modal imaging data are to be...
12.7K
Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

This article provides comprehensive step-by-step instructions for the acquisition of whole-body 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) PET/MRI scans for cancer staging of pediatric patients. The protocol was developed for children above 6 years, or old enough to comply with breath-hold instructions, but can be used for general anesthesia patients as...
15.2K